Reuters logo
BRIEF-Servier, Pfizer announce FDA clearance of IND application for UCART19
2017年3月9日 / 早上8点15分 / 8 个月前

BRIEF-Servier, Pfizer announce FDA clearance of IND application for UCART19

March 9 (Reuters) - Pfizer Inc:

* Servier and Pfizer announce FDA clearance of IND application for UCART19 in adult relapsed/refractory acute lymphoblastic leukemia

* Pfizer inc - U.S. FDA has granted Servier with an investigational new drug clearance to proceed in U.S. With clinical development of UCART19 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below